The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Large Volume Parenteral (LVP) Market Compare Between 2026 And 2030?
The large volume parenteral (lvp) market size has demonstrated robust expansion over recent years. Forecasts indicate it will expand from $13.53 billion in 2025 to $14.76 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.1%. Historically, this growth was driven by factors such as increasing hospitalization rates, a rise in intravenous fluid therapy usage, more surgical procedures, the broadening of critical care infrastructure, and the increase in infectious disease treatment.
The large volume parenteral (lvp) market is anticipated to experience robust expansion over the coming years. It is projected to reach $21.37 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.7%. This growth during the forecast period can be attributed to factors such as an expanding aging population, the increasing incidence of chronic diseases, a greater need for parenteral nutrition, the development of healthcare infrastructure in new markets, and an uptick in emergency and trauma care services. Key trends expected during this period involve a heightened demand for non-pvc and environmentally friendly lvp packaging, the proliferation of ready-to-use and premixed infusion solutions, a sharper emphasis on sterility and preventing contamination, the increasing application of lvps in critical care and emergency medicine, and a rise in the volume of hospital-based infusion therapies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12195&type=smp
Which Key Drivers Are Affecting The Large Volume Parenteral (LVP) Market Development?
The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the large-volume parenteral market going forward. Chronic diseases are long-term health issues or conditions, usually persisting for three months or more, with the potential for deterioration. Factors contributing significantly to the increase in chronic diseases include tobacco consumption, exposure to smoke, and inadequate nutrition. Patients with such conditions necessitate a balanced intake of vital nutrients to maintain vigor. The parenteral administration method ensures precise drug dosing as the majority of the medication enters circulation directly, bypassing the digestive system. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. Consequently, the rising prevalence of chronic diseases is a key factor propelling the expansion of the large-volume parenteral market.
Which Segment Types Are Examined In The Large Volume Parenteral (LVP) Market Segment Study?
The large volume parenteral (lvp) market covered in this report is segmented –
1) By Type: Soft Bag LVP, Plastic Bag LVP, Glass Bottle LVP
2) By Volume: 100 ML – 250 ML, 250 ML – 500 ML, 500 ML – 1000 ML, 1000 ML -2000 ML, 2000 And More
3) By Application: Basic Infusion, Therapeutics Infusion, Nutritious Infusion
4) By End-User: Hospital, Medical Centers, Other End Users
Subsegments:
1) By Soft Bag LVP: PVC Soft Bags, Non-PVC Soft Bags
2) By Plastic Bag LVP: Polypropylene Bags, Polyethylene Bags
3) By Glass Bottle LVP: Single-Use Glass Bottles, Multi-Dose Glass Bottles
What Trends Are Transforming The Large Volume Parenteral (LVP) Market?
Major companies operating within the Large Volume Parenteral (LVP) market are prioritizing the development of innovative smart infusion devices, such as intelligent large-volume infusion pumps. This focus addresses the increasing demand for safer, more automated, and connected intravenous therapy, driven by the expansion of hospital-based infusion services, remote patient monitoring, and the drive towards standardized, error-resistant medication delivery. An intelligent large-volume infusion pump is engineered to deliver high-volume IV fluids (LVP) and incorporates dose-error reduction software, connectivity for smart drug libraries, and alarm management. Unlike traditional infusion pumps, which rely purely on manual programming and limited automation, these next-generation pumps aid in preventing dosing mistakes, reducing workflow burden, and integrating with hospital IT systems. As an illustration, in April 2024, Baxter International Inc., a US-based pharmaceutical and medical-device company, obtained U.S. FDA clearance for its Novum IQ Large-Volume Infusion Pump, equipped with Dose IQ smart-dose software. This device supports high-rate fluid delivery, including large-volume infusions, offers safety features like drug library integration to minimize dosing errors, and enables connectivity to hospital electronic medical records and smart monitoring platforms. By facilitating the safe, automated, and reliable infusion of large volumes, the Novum IQ pump empowers healthcare providers to improve infusion accuracy, decrease the risk of dosing errors, and streamline high-volume IV therapy workflows.
Which Players Are Part Of The Competitive Landscape Of The Large Volume Parenteral (LVP) Market?
Major companies operating in the large volume parenteral (lvp) market are Pfizer Inc., Fresenius Kabi AG, Abbott Laboratories Inc., Otsuka Holdings Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Grifols S.A., Cipla Limited, ICU Medical Inc., Biocon Limited, Sichuan Kelun Pharmaceutical Co. Ltd., Alembic Pharmaceuticals Limited, Cadila Healthcare Ltd., Gland Pharma Limited, Akums Drugs & Pharmaceuticals Ltd., Beximco Pharmaceutical Ltd., Taj Pharmaceuticals Limited, Albert David Ltd., Amanta Healthcare Ltd., Unique Pharmaceutical Laboratories Ltd., Ahlcon Parenterals India Ltd., Parenteral Drugs Limited, Abaris Healthcare Pvt. Ltd., BML Parenteral Drugs, Denis Chem Lab Ltd., Pentagon Labs Ltd., DJ Labs Pvt. Ltd., Higgs Healthcare
Get The Full Large Volume Parenteral (LVP) Market Report:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Which Geographic Region Dominates The Large Volume Parenteral (LVP) Market?
North America was the largest region in the large volume parenteral (LVP) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large volume parenteral (lvp) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Large Volume Parenteral (LVP) Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/large-volume-parenteral-lvp-global-market-report
Browse Through More Reports Similar to the Global Large Volume Parenteral (LVP) Market 2026, By The Business Research Company
Small Volume Parenteral Market Report 2026
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Small Volume Parenteral Market Report
https://www.thebusinessresearchcompany.com/report/small-volume-parenteral-global-market-report
Parenteral Nutrition Market Report
https://www.thebusinessresearchcompany.com/report/parenteral-nutrition-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model